droplet-based PCR
Bio-Rad Laboratories, Qiagen Settle Digital PCR Patent Dispute
The firms said the settlement in the US District Court of Delaware is pursuant to a global settlement and patent cross-licensing agreement.
Bio-Rad Laboratories, Stilla Technologies Settle IP Lawsuit
Bio-Rad had alleged Stilla's Naica digital PCR system infringed on four patents held or licensed by the firm.
10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit
10x asked the US District Court for the Northern District of California to dismiss a suit, while another district court judge denied a 10x motion to dismiss.
The new chip enables the firm's digital PCR system to test up to 240 samples per day, and also uses lower volumes of sample input.
Bio-Rad Shutters Former GnuBio Facility as Part of Digital Biology R&D Consolidation
The company acquired GnuBio, which was developing a droplet-based sequencing platform, in 2014 for $39.7 million in cash and $10 million in contingent payments.